Member Info for MR.Spacetomato

Ferdie, get hold of some of the gel and rub your shares and wait 10 min.

Courtesy of MasksNew Norm:

"The Company is also pleased to confirm that the Coordinating (Principal) Investigator will be world-renowned Professor Arthur Burnett, MD, MBA, FACS, Distinguished Professor of Urology, Johns Hopkins School of Medicine, Brady Urological Institute. Professor Burnett is also a past President of the Sexual Medicine Society.

Professor Burnett commented: "In my humble opinion and as an expert in the field of erectile dysfunction management, I am very supportive of MED3000 and do believe that it offers an important and valid addition to the armamentarium of treatments we can offer our patients for erectile dysfunction. I am very pleased to support Futura Medical in the further clinical investigation of this novel topical treatment."

That's what I call a Big shot scientist praising FUM's product. This will be on the American News very shortly..keep an eye open to that. I wouldn't be surprised we see our CEO on Bloomberg soon giving an interview.

Morning lads.

Me too, I am working on another share to raise capitals to load on here and increase my holding. I am actually hoping this share waits for me to add more at these prices.
And our resident day trader is back then, I see. :0)

MasksNewNorm,

Superb post!!! That is exactly what investors in this company have to look at when buying shares here. Think of the potential returns and, in my view, a big pharma approaching us for a takeover. I am ecstatic I bought in this morning and will hold. Like many have said it here...this is looking like a life changing investment for those who got in at these lower prices.

Well done for the long termers here.

A question I have is: Whit the CE marking in the pipeline, what are our chances of FUM having discussions with manufacturers and potential BIG pharmas, as we speak ( or type), at the moment? I don't think FUM is just sitting on their bum waiting for the CE marking. Very interesting me thinks.

Less shares for us to share. :0)

Adamnskii, you may be right.. another farma with the same name. Nevermind.

Supertag, now I am not sure...are there two Futura Medical? Ist that possible. In my trading view it showed a stock with the same name.

FAMDF

IT will be interesting to see when the Nasdaq opens. This share is traded on the Nasdaq as well.

I aint got more cash to buy this under a quid! :0( I was in avacta at 49p last year and they climbed all the way to 270p after I sold at 115p a few months later and no where near where we are and not having even a product read for market!! Ilost out there but I can assure you, I will not lose out here. In for the big bucks now.

Good morning all

Just joined the boat with an average of 72p and not complaining. This looks very exciting and news will not take ages to arrive like other pharmas. FDA trial and EU CE marking and Asian companies already moving in! China will be a big nookies market alone.

£500 million for this? Are you dreaming? Just Chinese sales will bring that.

I wonder if you may have different flavours to cater for different tastes? Can you imagine that?

https://www.swatchgroup.com/en/swatch-group/innovation-powerhouse/industry-40/revolutionary-battery-belenos

Time to hit the sack. I will leave you with a couple of quotes:

“The [Vanadium] battery pack could charge twice as fast and weigh a third less than the Panasonic batteries currently used by
Tesla. For now Swatch’s focus is on the electric vehicle market with a goal of selling US$10-15bn of batteries by 2020.” – Nick
Hayek, CEO of Swatch Group

“I favor the fundamentals of vanadium, which is embarking on a stealthy run in price that very few exploration and mining
investors and commodities observers have yet noticed.” – John lee, Chairman and CEO of Prophecy Development Corp.

Correction, it was for £2,250 quid.

JC-130, it would make no difference which platform you were using in my view. I have both Barclays (ISA) and AJ Bell (SIPP) and had to try the buy button various times; just over 30 times on Barclays...and that was for £1,200 quid at 33p!! Ridiculous.

Thanks, kidsandcastles. Sharing here what I find as I did appreciate in my early days when others did the same for me. It encourages research in others, and not just listening to either rumpers or de-rampers in these forums.

strictlyin, good luck there mate. I didn't have any other side effects, apart from the muscle pain due to it being injected in the muscle; and yes, maybe a second side effect I just realised today...mixing my bulls and boars! :0)

strictlyinc

I blame on the Astrazeneca's jab I have just been given...arm still hurts two day after. :0)

ROCKLAWN... :0)) Animals lost in translation... I mean ...BULL. :0))

"Investors see ‘gold rush on steroids’ for green battery metals" FT
Henry Sanderson MARCH 12 2021

"Last month Mick Davis, the former boss of nickel and coal miner Xstrata, launched a fund, Vision Blue, to invest in battery metals. It has raised £75m and has already invested $30m in a project in Madagascar to produce graphite.."

"
Please use the sharing tools found via the share button at the top or side of articles. Copying articles to share with others is a breach of FT.com T&Cs and Copyright Policy. Email licensing@ft.com to buy additional rights. Subscribers may share up to 10 or 20 articles per month using the gift article service. More information can be found at https://www.ft.com/tour.
https://www.ft.com/content/fb1fa29b-7f2b-448b-ba47-05f16eccad97

“It’s a gold rush on steroids,” said Simon Moores, managing director of Benchmark Mineral Intelligence, which tracks the battery supply chain. “You’ve got the emergence of this green revolution where you have to build infrastructure from scratch. It’s not just China this time, it’s North America at the same time as China, and Europe at the same time as China.”

https://www.ft.com/content/fb1fa29b-7f2b-448b-ba47-05f16eccad97